Header Logo

Connection

Oliver Brooks to United States

Back to Details
This is a "connection" page, showing publications Oliver Brooks has written about United States.
Oliver Brooks
Connection Strength
1.463
United States
  1. Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR Morb Mortal Wkly Rep. 2023 Dec 08; 72(49):1327-1330.
    View in: PubMed
    Score: 0.156
  2. President's Message: Unfinished Business. J Natl Med Assoc. 2020 08; 112(4):333-334.
    View in: PubMed
    Score: 0.123
  3. Police Brutality and Blacks: An American Immune System Disorder. J Natl Med Assoc. 2020 Jun; 112(3):239-241.
    View in: PubMed
    Score: 0.122
  4. President's Message JNMA FEB 2020 Mothers Dying, Babies Crying. J Natl Med Assoc. 2020 Feb; 112(1):3-5.
    View in: PubMed
    Score: 0.119
  5. UNIVERSAL COVERAGE: Would a rose by any other name smell as sweet? J Natl Med Assoc. 2019 Dec; 111(6):578-579.
    View in: PubMed
    Score: 0.118
  6. Diversity in Medicine: The Low Levels of Black Physicians to Provide Black on Black Care is a Crime. J Natl Med Assoc. 2019 Oct; 111(5):469-470.
    View in: PubMed
    Score: 0.116
  7. President's message. J Natl Med Assoc. 2019 08; 111(4):346-348.
    View in: PubMed
    Score: 0.115
  8. The Erosion of a Pillar of Public Health: ACIP's Role and the Future of US Vaccine Policy Post-June 2025. Clin Infect Dis. 2026 07 08; 82(6):979-985.
    View in: PubMed
    Score: 0.046
  9. Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025. MMWR Morb Mortal Wkly Rep. 2025 Aug 28; 74(32):508-514.
    View in: PubMed
    Score: 0.044
  10. Use of COVID-19 Vaccines for Persons Aged =6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-2025. MMWR Morb Mortal Wkly Rep. 2024 Sep 19; 73(37):819-824.
    View in: PubMed
    Score: 0.041
  11. Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged =65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024 Apr 25; 73(16):377-381.
    View in: PubMed
    Score: 0.040
  12. Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged =6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023. MMWR Morb Mortal Wkly Rep. 2023 Oct 20; 72(42):1140-1146.
    View in: PubMed
    Score: 0.039
  13. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR Morb Mortal Wkly Rep. 2023 Oct 13; 72(41):1115-1122.
    View in: PubMed
    Score: 0.038
  14. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR Morb Mortal Wkly Rep. 2023 Aug 25; 72(34):920-925.
    View in: PubMed
    Score: 0.038
  15. Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 11; 71(45):1436-1441.
    View in: PubMed
    Score: 0.036
  16. Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged =18 years - United States, July 2022. MMWR Morb Mortal Wkly Rep. 2022 Aug 05; 71(31):988-992.
    View in: PubMed
    Score: 0.035
  17. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022. MMWR Morb Mortal Wkly Rep. 2022 Jul 01; 71(26):859-868.
    View in: PubMed
    Score: 0.035
  18. The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged =18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 18; 71(11):416-421.
    View in: PubMed
    Score: 0.034
  19. Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 21; 71(3):90-95.
    View in: PubMed
    Score: 0.034
  20. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021. MMWR Morb Mortal Wkly Rep. 2021 Nov 12; 70(45):1579-1583.
    View in: PubMed
    Score: 0.034
  21. The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021. MMWR Morb Mortal Wkly Rep. 2021 Nov 05; 70(44):1545-1552.
    View in: PubMed
    Score: 0.034
  22. Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged =16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021. MMWR Morb Mortal Wkly Rep. 2021 Sep 24; 70(38):1344-1348.
    View in: PubMed
    Score: 0.033
  23. Serving as Trusted Messengers about COVID-19 Vaccines and Therapeutics. J Natl Med Assoc. 2021 Feb; 113(1):6-7.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.